ETON vs. CW

Last updated Apr 1, 2026

Compare and contrast key facts about Eton Pharmaceuticals Inc (ETON) and Curtiss-Wright Corporation (CW).

Performance

ETON vs. CW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eton Pharmaceuticals Inc (ETON) and Curtiss-Wright Corporation (CW). The values are adjusted to include any dividend payments, if applicable.

ETON vs. CW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
ETON Eton Pharmaceuticals Inc	45.95%	26.95%	204.11%	55.32%	-34.27%	-47.23%	12.92%	17.65%	-2.08%
CW Curtiss-Wright Corporation	23.60%	55.66%	59.73%	33.98%	21.03%	19.86%	-16.83%	38.70%	-5.35%

Fundamentals

Market Cap ETON : $664.09M CW : $25.32B
EPS ETON : -$0.17 CW : $12.88
PS Ratio ETON : 8.30 CW : 7.32
PB Ratio ETON : 25.39 CW : 9.99
Total Revenue (TTM) ETON : $79.95M CW : $3.50B
Gross Profit (TTM) ETON : $42.74M CW : $1.30B
EBITDA (TTM) ETON : $2.80M CW : $749.24M

Returns By Period

In the year-to-date period, ETON achieves a 45.95% return, which is significantly higher than CW's 23.60% return.

ETON

• 1D: 9.30%
• 1M: 45.26%
• YTD: 45.95%
• 6M: 13.58%
• 1Y: 90.14%
• 3Y*: 85.76%
• 5Y*: 27.55%
• 10Y*: —

CW

• 1D: 7.76%
• 1M: -2.71%
• YTD: 23.60%
• 6M: 25.55%
• 1Y: 115.06%
• 3Y*: 57.36%
• 5Y*: 42.06%
• 10Y*: 25.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ETON vs. CW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETON

ETON Risk / Return Rank: 82
ETON Sharpe Ratio Rank: 87
ETON Sortino Ratio Rank: 85
ETON Omega Ratio Rank: 82
ETON Calmar Ratio Rank: 81
ETON Martin Ratio Rank: 73

CW

CW Risk / Return Rank: 97
CW Sharpe Ratio Rank: 98
CW Sortino Ratio Rank: 96
CW Omega Ratio Rank: 95
CW Calmar Ratio Rank: 98
CW Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ETON vs. CW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and Curtiss-Wright Corporation (CW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ETON	CW	Difference
Sharpe ratio Return per unit of total volatility	1.68	3.33	-1.65
Sortino ratio Return per unit of downside risk	2.42	3.64	-1.22
Omega ratio Gain probability vs. loss probability	1.30	1.51	-0.21
Calmar ratio Return relative to maximum drawdown	2.48	8.83	-6.35
Martin ratio Return relative to average drawdown	4.22	25.72	-21.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ETON vs. CW - Sharpe Ratio Comparison

The current ETON Sharpe Ratio is 1.68, which is lower than the CW Sharpe Ratio of 3.33. The chart below compares the historical Sharpe Ratios of ETON and CW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ETON	CW	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.68	3.33	-1.65
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.44	1.53	-1.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.84	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.32	0.59	-0.27

Correlation

The correlation between ETON and CW is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ETON vs. CW - Dividend Comparison

ETON has not paid dividends to shareholders, while CW's dividend yield for the trailing twelve months is around 0.14%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ETON Eton Pharmaceuticals Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
CW Curtiss-Wright Corporation	0.14%	0.17%	0.23%	0.35%	0.45%	0.51%	0.58%	0.47%	0.59%	0.46%	0.53%	0.76%

Drawdowns

ETON vs. CW - Drawdown Comparison

The maximum ETON drawdown since its inception was -79.94%, which is greater than CW's maximum drawdown of -59.19%. Use the drawdown chart below to compare losses from any high point for ETON and CW.

Drawdown Indicators

	ETON	CW	Difference
Max Drawdown Largest peak-to-trough decline	-79.94%	-59.19%	-20.75%
Max Drawdown (1Y) Largest decline over 1 year	-36.17%	-13.07%	-23.10%
Max Drawdown (5Y) Largest decline over 5 years	-77.18%	-27.21%	-49.97%
Max Drawdown (10Y) Largest decline over 10 years	—	-48.73%	—
Current Drawdown Current decline from peak	0.00%	-6.21%	+6.21%
Average Drawdown Average peak-to-trough decline	-38.43%	-13.95%	-24.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.21%	4.49%	+16.72%

Volatility

ETON vs. CW - Volatility Comparison

Eton Pharmaceuticals Inc (ETON) has a higher volatility of 18.53% compared to Curtiss-Wright Corporation (CW) at 15.01%. This indicates that ETON's price experiences larger fluctuations and is considered to be riskier than CW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ETON	CW	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.53%	15.01%	+3.52%
Volatility (6M) Calculated over the trailing 6-month period	35.91%	26.50%	+9.41%
Volatility (1Y) Calculated over the trailing 1-year period	54.09%	34.79%	+19.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	63.41%	27.60%	+35.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	63.70%	30.15%	+33.55%

Financials

ETON vs. CW - Profitability Comparison

The chart below illustrates the profitability comparison between Eton Pharmaceuticals Inc and Curtiss-Wright Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ETON - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eton Pharmaceuticals Inc reported a gross profit of 13.10M and revenue of 21.28M. Therefore, the gross margin over that period was 61.6%.

CW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Curtiss-Wright Corporation reported a gross profit of 355.44M and revenue of 946.98M. Therefore, the gross margin over that period was 37.5%.

ETON - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eton Pharmaceuticals Inc reported an operating income of 2.46M and revenue of 21.28M, resulting in an operating margin of 11.6%.

CW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Curtiss-Wright Corporation reported an operating income of 186.26M and revenue of 946.98M, resulting in an operating margin of 19.7%.

ETON - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eton Pharmaceuticals Inc reported a net income of 1.48M and revenue of 21.28M, resulting in a net margin of 7.0%.

CW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Curtiss-Wright Corporation reported a net income of 137.00M and revenue of 946.98M, resulting in a net margin of 14.5%.